Alnylam s gene silencing drug wins FDA approval

Alnylam Pharmaceuticals Incs drug for a rare hereditary disease won U.S. regulatory approval on Friday, becoming the first approved treatment from a new class of medicines that use gene silencing technology." /> Reuters 8/10/2018 6:15:19 PM

Read From Source Health Similar News

Similar News

Most Read

© Copyright 2016 Hnvnews.co.uk ( Met-Ay Bilişim Ltd.Şti. ) - All Rights Reserved.